168 results on '"Kampmann, Peter"'
Search Results
2. Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial
3. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)
4. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
5. Adaptive Steuerung für Unterwasser-Greifsysteme
6. Multimodale Unterwasser-Sensorik für Umweltkartierung und Fahrzeugnavigation
7. Intelligenter Antrieb
8. Low vitamin C status and hypermobility‐related disorders in patients with bleeding disorder of unknown cause.
9. A national Danish proof of concept on feasibility and safety of home -based intensive chemotherapy in patients with acute myeloid leukemia
10. Prostatic artery embolization in men with severe hemophilia a: a case report of two patients
11. Adaptive Control for Underwater Gripping Systems
12. Underwater Multi-modal Sensing for Environmental Mapping and Vehicle Navigation
13. Intelligent Propulsion
14. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
15. Exoskelette und künstliche Intelligenz in der klinischen Rehabilitation
16. Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations
17. Gene therapy with adeno-associated virus vector 5–human factor IX in adults with hemophilia B
18. Inspection and maintenance of industrial infrastructure with autonomous underwater robots
19. S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS
20. Adaptive Control for Underwater Gripping Systems
21. Underwater Multi-modal Sensing for Environmental Mapping and Vehicle Navigation
22. Intelligent Propulsion
23. Towards a Cognitive Architecture for Marine Robots
24. Temperature–Humidity-Dependent Wind Effects on Physiological Heat Strain of Moderately Exercising Individuals Reproduced by the Universal Thermal Climate Index (UTCI)
25. Intuitive Interaction with Robots – Technical Approaches and Challenges
26. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
27. Marine Snow Simulation and Elimination in Video
28. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
29. Towards a fine-manipulation system with tactile feedback for deep-sea environments
30. Tactile Sensors Based Object Recognition and 6D Pose Estimation
31. Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
32. A software architecture for resilient long term autonomous missions of AUVs
33. Application of whole‐exome sequencing to direct the specific functional testing and diagnosis of rare inherited bleeding disorders in patients from the Öresund Region, Scandinavia
34. Prostatic artery embolization in men with severe hemophilia a:a case report of two patients
35. SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia
36. Work-up of thrombophilia
37. HIV Comorbid Infection and Liver-Directed AAV-Based Gene Therapy in Adults with Severe and Moderately Severe Hemophilia B: Efficacy and Safety Results from Phase 2b and the Pivotal Phase 3 HOPE-B Trials 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec
38. Long-Term Bleeding Protection, Sustained FIX Activity, Reduction of FIX Consumption and Safety of Hemophilia B Gene Therapy: Results from the HOPE-B Trial 3 Years after Administration of a Single Dose of Etranacogene Dezaparvovec in Adult Patients with Severe or Moderately Severe Hemophilia B
39. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2
40. Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia
41. Histiocytic Sarcoma:Challenging Course, Dismal Outcome
42. SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni
43. A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2
44. Histiocytic Sarcoma: Challenging Course, Dismal Outcome
45. Tactile Sensors Based Object Recognition and 6D Pose Estimation
46. First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies
47. Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis: A Pre and Post-Intervention Analysis
48. AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirm Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 5 Years
49. Venøs tromboembolisk sygdom ved COVID-19
50. Introduction of a Comprehensive Diagnostic and Interdisciplinary Management Approach in Haematological Patients with Mucormycosis : A Pre and Post-Intervention Analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.